Chapter 1 Research Methodology & Scope
1.1 Market Segmentation and Scope
1.1.1 End-use
1.1.2 Estimates and forecast timeline
1.2 Research methodology
1.3 Information procurement
1.3.1 Purchased database
1.3.2 Nova one advisor’s internal database
1.3.3 Secondary sources
1.3.4 Primary research
1.3.5 Details of primary research
1.4 Information or Data Analysis
1.4.1 Data analysis models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.1.1 Approach 1: Commodity Flow Approach
1.7 List of Secondary Sources
1.8 List of Primary Sources
1.9 List of Abbreviations
1.10 Objectives
1.10.1 Objective 1
1.10.2 Objective 2
1.10.3 Objective 3
1.10.4 Objective 4
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights
Chapter 3 U.S. Integrated Operating Rooms Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent market outlook
3.1.2 Ancillary market outlook
3.2 Technology Trends
3.3 Market Dynamics
3.3.1 Market driver analysis
3.3.1.1 Increasing demand for minimally invasive and image-guided procedures
3.3.1.2 Growing popularity of integrated ORs
3.3.1.3 Technologically advanced healthcare IT infrastructure
3.3.1.4 Rising number of ambulatory surgery centers
3.3.2 Market restraint analysis
3.3.2.1 High cost associated with integrated operating rooms
3.3.3 Market Opportunity Analysis
3.3.3.1 Increasing investments by stakeholders
3.3.4 Market Challenges Analysis
3.3.4.1 Cyber security threats
3.4 U.S. Integrated Operating Rooms: Market Analysis Tools
3.4.1 Industry analysis - Porter’s
3.4.1.1 Bargaining power of buyers:
3.4.1.2 Bargaining power of suppliers:
3.4.1.3 Competitive rivalry:
3.4.1.4 Threat of new entrants:
3.4.1.5 Threat of substitutes:
3.4.2 SWOT by PESTLE analysis
3.4.2.1 Political landscape
3.4.2.2 Environmental landscape
3.4.2.3 Social landscape
3.4.2.4 Technology landscape
3.4.2.5 Legal landscape
3.4.2.6 Economic landscape
Chapter 4 Impact of COVID-19 on U.S. Integrated Operating Rooms Market
4.1 Disease Prevalence Analysis
4.2 Demand Analysis
4.3 Recent Developments & Strategic Outcomes
Chapter 5 U.S. Integrated Operating Rooms Market: End-use Estimates and Forecasts to 2032
5.1 Definition and Scope
5.2 End-Use Market Share Analysis, 2023 & 2032
5.3 Segment Dashboard
5.4 U.S. Integrated Operating Rooms Market, by End-use, 2020 to 2032
5.5 Market Size & Forecasts and Trend Analyses, 2020 to 2032
5.5.1 Hospitals
5.5.1.1 Hospitals market, 2020 - 2032
5.5.2 Ambulatory Surgical Centers
5.5.2.1 Ambulatory Surgical Centers market, 2020 - 2032
5.5.3 Hospital-based Outpatient Department (HOPD)
5.5.3.1 Hospital-based Outpatient Department (HOPD) market, 2020 - 2032
5.5.4 Office-based Labs (OBLs)
5.5.4.1 Office-based Labs (OBLs) market, 2020 - 2032
Chapter 6 U.S. Integrated Operating Rooms Market: Competitive Analysis
6.1 Recent Developments & Impact Analysis
6.2 Company/Competition Categorization (Key Innovators, Market Leaders, Emerging Players)
6.2.1 Public Companies
6.2.1.1 Estimated Company Market Share Analysis (2023, %)
6.2.1.2 Major Deals & Strategic Alliances Analysis
6.2.2 Exhaustive List of Players
6.2.3 Detailed List of Integrated Operating Rooms Market Participants
6.2.4 Detailed List of Video Over IP Market Participants
6.2.5 Detailed List of Surgical Display Market Participants
6.2.6 Detailed List of Surgical Teleconferencing Market Participants
6.2.7 Detailed List of Surgical in Wall Consoles Market Participants
Chapter 7 Company Profiles
7.1 Stryker
7.1.1 Company Overview
7.1.2 Financial Performance
7.1.3 Product Benchmarking
7.1.4 Strategic Initiatives
7.2 Brainlab AG
7.2.1 Company Overview
7.2.2 Financial Performance
7.2.3 Product Benchmarking
7.2.4 Strategic Initiatives
7.3 Barco
7.3.1 Company Overview
7.3.2 Financial Performance
7.3.3 Product Benchmarking
7.3.4 Strategic Initiatives
7.4 Steris Plc
7.4.1 Company Overview
7.4.2 Financial Performance
7.4.3 Product Benchmarking
7.4.4 Strategic Initiatives
7.5 Arthrex, Inc.
7.5.1 Company Overview
7.5.2 Financial Performance
7.5.3 Product Benchmarking
7.5.4 Strategic Initiatives
7.6 Karl Storz
7.6.1 Company Overview
7.6.2 Financial Performance
7.6.3 Product Benchmarking
7.6.4 Strategic Initiatives
7.7 Olympus Corporation
7.7.1 Company Overview
7.7.2 Financial Performance
7.7.3 Product Benchmarking
7.7.4 Strategic Initiatives
7.8 Getinge AB
7.8.1 Company Overview
7.8.2 Financial Performance
7.8.3 Product Benchmarking
7.8.4 Strategic Initiatives
7.9 Skytron, LLC
7.9.1 Company Overview
7.9.2 Financial Performance
7.9.3 Product Benchmarking
7.9.4 Strategic Initiatives
7.10 Caresyntax
7.10.1 Company Overview
7.10.2 Financial Performance
7.10.3 Product Benchmarking
7.10.4 Strategic Initiatives
7.11 Sony
7.11.1 Company Overview
7.11.2 Financial Performance
7.11.3 Product Benchmarking
7.11.4 Strategic Initiatives